OWC Pharmaceutical Research Corp. (OWCP)

OWCP Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Sep 30, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Revenue	-	-	-	0.05	-	-
Gross Profit	-	-	-	0.05	-	-
Selling, General & Admin	2.15	2.86	4.11	2.01	1.38	4.87
Research & Development	0.99	0.71	0.44	0.14	0.27	0.16
Operating Expenses	3.14	3.57	4.55	2.15	1.65	5.03
Operating Income	-3.14	-3.57	-4.55	-2.1	-1.65	-5.03
Interest Expense	-0.01	-0.83	-0.01	-	-0	-0.04
Interest & Investment Income	-	-	-	-	-	0
Currency Exchange Gain (Loss)	-	-	-	-0.02	-	-
Other Non Operating Income (Expenses)	5.21	-5.14	-	-0.17	-	-
EBT Excluding Unusual Items	2.07	-9.53	-4.56	-2.29	-1.65	-5.07
Legal Settlements	-0.73	-0.73	-	-	-	-
Pretax Income	1.34	-10.26	-4.56	-2.29	-1.65	-5.07
Net Income	1.34	-10.26	-4.56	-2.29	-1.65	-5.07
Preferred Dividends & Other Adjustments	3.63	2.45	-	-	-	-
Net Income to Common	-2.29	-12.71	-4.56	-2.29	-1.65	-5.07
Shares Outstanding (Basic)	185	148	145	96	81	52
Shares Outstanding (Diluted)	185	148	145	96	81	52
Shares Change (YoY)	25.41%	1.97%	50.69%	19.57%	54.36%	175.06%
EPS (Basic)	-0.01	-0.09	-0.03	-0.02	-0.02	-0.10
EPS (Diluted)	-0.01	-0.09	-0.03	-0.02	-0.02	-0.10
Free Cash Flow	-2.75	-2.53	-1.2	-0.53	-1.22	-0.63
Free Cash Flow Per Share	-0.01	-0.02	-0.01	-0.01	-0.01	-0.01
Gross Margin	-	-	-	100.00%	-	-
Operating Margin	-	-	-	-4196.15%	-	-
Profit Margin	-	-	-	-4574.66%	-	-
Free Cash Flow Margin	-	-	-	-1062.26%	-	-
EBITDA	-3.13	-3.56	-4.55	-2.09	-1.64	-5.03
D&A For EBITDA	0.01	0.01	0.01	0.01	0.01	0
EBIT	-3.14	-3.57	-4.55	-2.1	-1.65	-5.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.